Healthcare provider profile · identity verified

Luis E Moreno, MD

General Practice · CATANO, PR · NPI 1720042054

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	648	110
Levothyroxine Sodium	Levothyroxine Sodium	647	125
Atorvastatin Calcium	Atorvastatin Calcium	570	175
Famotidine	Famotidine	534	102
Omeprazole	Omeprazole	531	95
Amlodipine Besylate	Amlodipine Besylate	502	145
Losartan Potassium	Losartan Potassium	471	141
Metformin Hcl	Metformin Hcl	404	115
Montelukast Sodium	Montelukast Sodium	384	83
Tamsulosin Hcl	Tamsulosin Hcl	352	59
Metoprolol Succinate	Metoprolol Succinate	315	95
Simvastatin	Simvastatin	270	78
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	250	74
Sertraline Hcl	Sertraline Hcl	229	65
Synthroid	Levothyroxine Sodium	207	44
Alendronate Sodium	Alendronate Sodium	202	35
Rosuvastatin Calcium	Rosuvastatin Calcium	181	53
Trazodone Hcl	Trazodone Hcl	181	58
Nifedipine Er	Nifedipine	173	43
Furosemide	Furosemide	171	42
Cilostazol	Cilostazol	164	30
Clopidogrel	Clopidogrel Bisulfate	143	25
Baclofen	Baclofen	138	65
Diclofenac Potassium	Diclofenac Potassium	136	62
Lisinopril	Lisinopril	134	41
Glimepiride	Glimepiride	126	33
Glipizide	Glipizide	124	37
Donepezil Hcl	Donepezil Hcl	122	37
Latanoprost	Latanoprost	118	17
Humulin N	Insulin Nph Human Isophane	117	18
Pantoprazole Sodium	Pantoprazole Sodium	111	23
Carvedilol	Carvedilol	110	21
Nabumetone	Nabumetone	107	43
Temazepam	Temazepam	101	20
Triamcinolone Acetonide	Triamcinolone Acetonide	100	55
Allopurinol	Allopurinol	96	18
Albuterol Sulfate Hfa	Albuterol Sulfate	86	26
Fluticasone Propionate	Fluticasone Propionate	85	33
Diclofenac Sodium	Diclofenac Sodium	80	25
Hydralazine Hcl	Hydralazine Hcl	77	14
Memantine Hcl	Memantine Hcl	77	14
Xarelto	Rivaroxaban	77	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	71	13
Irbesartan	Irbesartan	65	19
Eliquis	Apixaban	62	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	62	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	61	11
Doxazosin Mesylate	Doxazosin Mesylate	59	15
Finasteride	Finasteride	55	12
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	49	12
Spironolactone	Spironolactone	49	suppressed
Glyxambi	Empagliflozin/Linagliptin	48	suppressed
Naproxen	Naproxen	47	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	44	43
Duloxetine Hcl	Duloxetine Hcl	43	13
Tolterodine Tartrate Er	Tolterodine Tartrate	43	14
Fenofibrate	Fenofibrate,micronized	42	11
Hydrochlorothiazide	Hydrochlorothiazide	42	15
Pioglitazone Hcl	Pioglitazone Hcl	40	14
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	39	suppressed
Clonazepam	Clonazepam	39	16
Farxiga	Dapagliflozin Propanediol	39	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	13
Lantus	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Trueplus Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	39	11
Ciclopirox	Ciclopirox Olamine	38	24
Pentoxifylline	Pentoxifylline	38	suppressed
Warfarin Sodium	Warfarin Sodium	38	suppressed
Azithromycin	Azithromycin	37	33
Lactulose	Lactulose	36	12
Tizanidine Hcl	Tizanidine Hcl	36	27
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	11
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Ezetimibe	Ezetimibe	31	12
Atenolol	Atenolol	29	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	29	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Digoxin	Digoxin	28	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	28	11
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	27	11
Folic Acid	Folic Acid	26	suppressed
Sucralfate	Sucralfate	26	suppressed
Clotrimazole	Clotrimazole	25	12
Alfuzosin Hcl Er	Alfuzosin Hcl	24	suppressed
Timolol Maleate	Timolol Maleate	24	suppressed
Trueplus Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Insulin Lispro	Insulin Lispro	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	13
Methylprednisolone	Methylprednisolone	19	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	18	suppressed
Cephalexin	Cephalexin	17	16
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Trueplus Insulin Syringe	Syringe And Needle,insulin,1ml	17	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Lumigan	Bimatoprost	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Levofloxacin	Levofloxacin	14	14
Lorazepam	Lorazepam	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Humulin R	Insulin Regular, Human	13	suppressed
Risperidone	Risperidone	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Advocate Syringes	Syringe-Needle,insulin,0.5 Ml	11	suppressed
Cabergoline	Cabergoline	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Enulose	Lactulose	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Nitroglycerin Patch	Nitroglycerin	11	suppressed
Theophylline Er	Theophylline Anhydrous	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error